Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

No Let-Up On DOJ Medicare Advantage Fraud Probes No Photo Available

Theresa Schliep

Federal scrutiny of Medicare Advantage fraud is showing no signs of abating.

Sanford-Marshfield Tie-Up Portends More Cross-Market Deals No Photo Available

Yeji Jesse Lee

A merger between two Midwest health systems is evidence of hospitals' desire to strike deals with players in other markets, according ... (more story)

Ex-FDA Head Calls For Congressional Action On Medical AI No Photo Available

Dan McKay

A former head of the U.S. Food and Drug Administration has some unexpected advice for policymakers wrestling with how to regulate arti... (more story)